Author:
Gutzmer R.,Werfel T.,Kapp A.,Elsner J.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Averbuch SD (2002) Lung cancer prevention: retinoids and the epidermal growth factor receptor-a phoenix rising? Clin Cancer Res 8:1–3
2. Baselga J, Rischin D, Ranson M et al. (2002) Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J Clin Oncol 20:4292–4302
3. Boucher KW, Davidson K, Mirakhur B et al. (2002) Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibody. J Am Acad Dermatol 47:632–633
4. Braun-Falco M, Holtmann C, Lordick F, Ring J (2005) Follikuläre Arzneimittelreaktion auf Cetuximab. Eine häufige Nebenwirkung bei der Therapie metastasierter kolorektaler Karzinome. Hautarzt online, publiziert 1. Juli 2005
5. Bunn PA Jr,Franklin W (2002) Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer. Semin Oncol 29:38–44
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献